Benavent, Diego http://orcid.org/0000-0001-9119-5330
Peiteado, Diana
Martinez-Huedo, María Ángeles
Hernandez-Hurtado, María
Balsa, Alejandro
de Miguel, Eugenio
Article History
Received: 10 July 2020
Accepted: 7 June 2021
First Online: 24 June 2021
Competing interests
: DB: Speaking fees Abbvie, Roche. DP: Speaking fees from AbbVie, Roche, and MSD and Grant/research support from AbbVie, Eli Lilly, MSD, and Roche. AB: Grant/research support: Abbvie, Pfizer, Novartis, BMS, Nordic, Sanofi. Consultant: Abbvie, Pfizer, Novartis, BMS, Nordic, Sanofi, Sandoz, Lilly. Speakers bureau: Pfizer, Novartis, UCB, Nordic, Sanofi, Sandoz, Lilly. EDM: Grant/research support from: AbbVie, Novartis, Pfizer, Consultant for: AbbVie, Novartis, Pfizer, Speakers bureau: AbbVie, BMS, MSD, Novartis, Pfizer, UCB, Roche. No other disclosures relevant to this article were reported.